Top Performer’s Surge in the Cannabis SectorIn February 2024, top Canadian cannabis stocks showed mixed performance amid evolving market dynamics. Companies like Canopy Growth, Aurora Cannabis, and Tilray Brands remained focal points for investors. Market movements were influenced by quarterly earnings reports, with some companies exceeding expectations and others falling short. This period saw significant attention to operational efficiencies and international expansion efforts. Additionally, updates on pr ...

Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -100%. A quarter ago, it was expected that this company would post a loss of $0.05 per share when it actually produced a loss of $0.05, delivering no surprise.Over the last four quarters, the company has surpassed cons ...

Aurora Cannabis Inc. (NASDAQ:ACB) Q3 2024 Earnings Conference Call February 8, 2024 8:00 AM ET Company Participants Ananth Krishnan - VP, Corporate Development & Strategy Miguel Martin - CEO Glen Ibbott - CFO Conference Call Participants Frederico Gomes - ATB Capital Markets Matt Bottomley - Canaccord Tamy Chen - BMO Capital Markets Douglas Miehm - RBC Capital Markets Pablo Zuanic - Zuanic Associates Operator Greetings, and welcome to the Aurora Cannabis Third Quarter 2024 Results Conference Call. All parti ...

Aurora Cannabis (NASDAQ:ACB) stock is climbing higher on Thursday after completing its acquisition of MedReleaf Australia.Aurora Cannabis used a wholly-owned subsidiary to acquire the 90% stake in MedReleaf Australia that it didn’t already own. The deal is worth $50 million with Aurora Cannabis paying $9.45 million in cash and the remaining in ACB stock.The acquisition of MedReleaf Australia gives Aurora Cannabis a firm footing in the medical cannabis market in Australia. This market is valued at $400 milli ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Aurora Cannabis Inc (NASDAQ: ACB) is in focus today after buying the remaining 90% stake in MedReleaf Australia for about AU$50 million ($32.45 million).Details of Aurora-MedReleaf transactionCopy link to sectionThe licensed cannabis producer paid $9.45 million in cash and the remaining in stock. Aurora caught interest in buying MedReleaf because it’s currently the second largest player in medical cannabis in Australia. Miguel Martin – chief executive of the Edmonton-headquartered firm said in a press relea ...

                                                                                                       NASDAQ | TSX: ACB Re-Affirms Commitment to Achieving Positive Free Cash Flow1 This Calendar Year, Delivers Fifth Consecutive Quarter of Positive Adjusted EBITDA1 Aurora Becomes the Largest Global Medical Cannabis Company in Nationally Legal Markets Following the Acquisition of MedReleaf Australia Strong YoY Growth of 41% in High Margin International Net Cannabis Revenue1 Cash position of over $200 Millio ...

NASDAQ | TSX: ACB Aurora becomes the largest global medical cannabis company operating in nationally legal markets. MedReleaf Australia holds the #2 position in medical cannabis within the rapidly growing ~AUD$400 million1 Australian market. Transaction is expected to be immediately accretive to Adjusted EBITDA2 and accelerate the Company's plan for Positive Free Cash Flow2 generation in calendar 2024. EDMONTON, AB, Feb. 8, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) ...

The Leading Cannabis ETFs to Consider in 2024Cannabis ETFs are garnering attention in 2024 as the industry shows promising growth. Key players like MJ, MSOS, and CNBS dominate this sector. These ETFs offer diversified exposure to cannabis-related stocks. This includes companies involved in cultivation, production, and retail. The U.S. cannabis industry has seen remarkable growth. Statistics reveal a projected market size of over $30 billion by 2025. This growth is fueled by expanding legalization and increa ...

The last decade saw a trend for destigmatization of the use of psychoactive substances accompanied by a wave of legislation either legalizing or decriminalizing mostly marijuana-based products – both for medical and recreational use.These developments brought the creation of numerous firms focusing on cannabis products, and many of them have become popular publicly traded companies and exciting investment opportunities.Now, a new Food and Drug Administration (FDA) report stating that Marijuana is eligible f ...